Literature DB >> 26792854

Guillain-Barre syndrome and Hashimoto's thyroiditis.

M Toudou Daouda1, N S Obenda2, L Maazou3, D Camara2, Z Souirti4, A Elmidaoui4, M F Belahsen4.   

Abstract

Entities:  

Year:  2016        PMID： 26792854      PMCID： PMC4986428          DOI： 10.1093/qjmed/hcw007

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  5 in total

Review 1.  Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki; Hans-Peter Hartung
Journal:  N Engl J Med       Date:  2012-06-14       Impact factor: 91.245

2.  Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.

Authors:  C W Ang; N Yuki; B C Jacobs; M Koga; P A Van Doorn; P I Schmitz; F G Van Der Meché
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  Concurrence of Multifocal Motor Neuropathy and Hashimoto's Thyroiditis.

Authors:  Suk-Won Ahn; Su-Hyun Kim; Byung-Su Park; Jeong-In Cha; Sung-Min Kim; Jung-Joon Sung; Kwang-Woo Lee
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

4.  Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies.

Authors:  Toshihiro Yamazaki; Megumi Suzuki; Togo Irie; Takeshi Watanabe; Hirotsugu Mikami; Seiitsu Ono
Journal:  Clin Neurol Neurosurg       Date:  2008-05-02       Impact factor: 1.876

5.  Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association.

Authors:  Antonio Toscano; Carmelo Rodolico; Salvatore Benvenga; Paolo Girlanda; Matilde Laurà; Anna Mazzeo; Eduardo Nobile-Orazio; Francesco Trimarchi; Giuseppe Vita; Corrado Messina
Journal:  Neuromuscul Disord       Date:  2002-08       Impact factor: 4.296
  5 in total
  1 in total

1.  The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.

Authors:  Lingxin Kong; Xiujuan Wu; Yanwei Cheng; Shan Liu; Kangding Liu; Chunrong Li
Journal:  Neurol Sci       Date:  2022-04-26       Impact factor: 3.830
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.